(Q36343495)

13 August 2017

1 reference

title

New insight into the pathophysiology of lipid abnormalities in type 2 diabetes (English)

1 reference

13 August 2017

0 references

1 reference

Vergès B

1

1 reference

PubMed ID

16357786

13 August 2017

language of work or name

1 reference

1 November 2005

1 reference

13 August 2017

Diabetes and Metabolism

1 reference

13 August 2017

31

1 reference

13 August 2017

429-439

1 reference

13 August 2017

5

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Intracellular assembly of VLDL: two major steps in separate cell compartments

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Insulin and lipoprotein metabolism with special reference to the diabetic state

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Modification of lipoproteins in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

The dyslipoproteinemias of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Diabetic hypertriglyceridemia: evidence for three clinical syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Expression of apolipoprotein B in vitro in cell-free lysates of HepG2 cells: evidence that insulin modulates ApoB synthesis at the translational level

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed ham

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Hypertriglyceridemic Very Low Density Lipoproteins Induce Triglyceride Synthesis and Accumulation in Mouse Peritoneal Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Glycation of very low density lipoprotein from rat plasma impairs its catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

In vitro degradation of very low density lipoprotein from diabetic patients by lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Greater effect of diabetes on LDL size in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Endothelial dysfunction in men with small LDL particles

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Lipoprotein glycation and its metabolic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Reverse cholesterol transport in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Decreased ability of high density lipoproteins to transfer cholesterol esters in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Diabetes, lipids, and adipocyte secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

The role of TNF alpha in adipocyte metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970213-6

7 January 2021

10.1016/S1262-3636(07)70213-6

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16357786